| Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction H Chen, M Li, L Liu, X Dang, D Zhu, G Tian Medicine 98 (26), e16267, 2019 | 100 | 2019 |
| Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A A Franco, X Dang, EK Walton, JN Ho, B Zablocka, C Ly, TM Miller, ... elife 9, e61119, 2020 | 42 | 2020 |
| Discovery of 6-phenylhexanamide derivatives as potent stereoselective mitofusin activators for the treatment of mitochondrial diseases X Dang, L Zhang, A Franco, J Li, AG Rocha, S Devanathan, RE Dolle, ... Journal of medicinal chemistry 63 (13), 7033-7051, 2020 | 31 | 2020 |
| Effects of long-term psychological intervention on blood pressure and health-related quality of life in patients with hypertension among the Chinese working population L Liu, M Li, S Song, A Shi, S Cheng, X Dang, H Chen, H Zhang, A Ziguli, ... Hypertension Research 40 (12), 999-1007, 2017 | 21 | 2017 |
| Reciprocal regulation of mitofusin 2-mediated mitophagy and mitochondrial fusion by different PINK1 phosphorylation events J Li, X Dang, A Franco, GW Dorn Frontiers in Cell and Developmental Biology 10, 868465, 2022 | 20 | 2022 |
| Mitochondrial phenotypes in genetically diverse neurodegenerative diseases and their response to mitofusin activation X Dang, EK Walton, B Zablocka, RH Baloh, ME Shy, GW Dorn Cells 11 (6), 1053, 2022 | 11 | 2022 |
| Predicting mitochondrial dynamic behavior in genetically defined neurodegenerative diseases GW Dorn, X Dang Cells 11 (6), 1049, 2022 | 10 | 2022 |
| Mitochondrial dysfunction and pharmacodynamics of mitofusin activation in murine Charcot-Marie-Tooth disease type 2A A Franco, X Dang, L Zhang, PB Molinoff, GW Dorn Journal of Pharmacology and Experimental Therapeutics 383 (2), 137-148, 2022 | 9 | 2022 |
| Pharmacophore-based design of phenyl-[hydroxycyclohexyl] cycloalkyl-carboxamide mitofusin activators with improved neuronal activity X Dang, SB Williams, S Devanathan, A Franco, L Fu, PR Bernstein, ... Journal of medicinal chemistry 64 (17), 12506-12524, 2021 | 9 | 2021 |
| Piperine derivatives enhance fusion and axonal transport of mitochondria by activating mitofusins L Zhang, X Dang, A Franco, H Zhao, GW Dorn Chemistry 4 (3), 655-668, 2022 | 6 | 2022 |
| Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases A Franco, CE Walton, X Dang Life 12 (12), 2110, 2022 | 5 | 2022 |
| Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis X Dang, L Zhang, A Franco, GW Dorn II Human molecular genetics 32 (7), 1208-1222, 2023 | 4 | 2023 |
| A human mitofusin 2 mutation can cause mitophagic cardiomyopathy A Franco, J Li, DP Kelly, RE Hershberger, AJ Marian, RM Lewis, M Song, ... Elife 12, e84235, 2023 | 2 | 2023 |
| A human mitofusin 2 mutation causes mitophagic cardiomyopathy A Franco, J Li, DP Kelly, RE Hershberger, AJ Marian, RM Lewis, M Song, ... bioRxiv, 2022.11. 22.517462, 2022 | | 2022 |
| Correction to “Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases” X Dang, L Zhang, A Franco, J Li, AG Rocha, S Devanathan, RE Dolle, ... Journal of Medicinal Chemistry 63 (17), 10086-10086, 2020 | | 2020 |
